Lars A. Dejgaard et al. JACC 2018;72:

Slides:



Advertisements
Similar presentations
Devices and the older patient with syncope Michael Gammage, Reader in Cardiovascular Medicine MHRA Committee for Safety of Devices.
Advertisements

The Decision of Target of BANSMOM m Yumiko Kimezawa November 25, 2011RPS1.
2. What are the common and uncommon symptoms of MVP?
The Cardiac Cycle Follow the events of the cardiac cycle and match them with a graph that shows changes in pressure within the left side of the heart and.
Objectives 1. Discuss heart sounds 2. Describe the major types of cardiac valve disorders 3. Explain how a myocardial infarction might occur. 4. Describe.
24hr ECG Interpretation 17 th September 2015 Trinity Park, Ipswich Andrew Chalk, Chief Cardiac Physiologist Jamie Williams, Senior Cardiac Physiologist.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Entrainment mapping and radiofrequency catheter.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Novel Insight Into the Natural History of Short.
Figure 1 Alcohol consumption. A
Figure 2. Patient`s 12 Lead Electrocardiogram when she presented with palpitations and cardiac device firing on her latest hospital admission this year.
From: Heart Disease Screening of Schoolchildren in Taiwan
Circ Arrhythm Electrophysiol
The Automated Implantable Cardiac Defibrillator
Fig. 3. Mitral valve reconstruction in a normal subject (A) and in a patient with severe mitral regurgitation due to P2 scallop flail and prolapse and.
Cardiac Arrhythmias in Acute Myocardial Infarction II
Circ Arrhythm Electrophysiol
Mackram F. Eleid et al. JIMG 2016;9:
Spontaneous and inducible arrhythmias in dnNRSF Tg mice.
BENEFIT Trial design: Patients with positive serologic tests for T. Cruzi and cardiomyopathy were randomized to benznidazole 300 mg daily for days.
David Filgueiras-Rama, and José Jalife JACEP 2016;2:1-13
Figure 3 Imaging characteristics of cardiac myxoma
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
Sudden Cardiac Death, Mitral Valve Prolapse, and Long QT Syndrome
Lars A. Dejgaard et al. JACC 2018;72:
Lars A. Dejgaard et al. JACC 2018;72:
Systemic Sarcoidosis and Cardiac Conduction Abnormalities
Muaz M. Abudiab et al. JIMG 2017;j.jcmg
Joanna Chikwe et al. JACC 2017;69:
Alexander Ghanem et al. JACC 2010;55:
David D. Berg et al. JACC 2018;71:
Santiago Rivera et al. JACEP 2015;1:
Santiago Rivera et al. JACEP 2015;1:
Figure 2 A patient with aortic stenosis and mitral regurgitation
David F. Katz et al. JACEP 2016;j.jacep
Sébastien P.J. Krul et al. JACEP 2015;1:
Volume 14, Issue 6, Pages (June 2017)
Electromyographic responses of the diaphagm to cervical magnetic stimulations (CMS), recorded with the intramuscular electrodes implanted for diaphragm.
Volume 11, Issue 2, Pages (February 2014)
Patrick M. Boyle et al. JACEP 2018;4:
Physiology, Health & Exercise
John L. Sapp et al. JACEP 2017;3:
Spectrum of cardiac manifestations from aconitine poisoning
Øyvind H. Lie et al. JACEP 2018;j.jacep
Volume 13, Issue 1, Pages (January 2016)
Recurrent idiopathic polymorphic ventricular tachycardia/ventricular fibrillation successfully treated by cardiac sympathetic denervation  Faisal Matto,
David F. Katz et al. JACEP 2017;3:20-28
Volume 11, Issue 1, Pages (January 2014)
R. Harika, K. Bermas, C. Hughes, A. Al-Khafaji, M. Iyer, D.J. Wallace 
Pugazhendhi Vijayaraman et al. JACEP 2015;1:
Mitral valve repair results in suppression of ventricular arrhythmias and normalization of repolarization abnormalities in mitral valve prolapse  Wael.
HeartRhythm Case Reports
Three-dimensional (3D) measurement of the outer and inner/effective mitral annular area. Three-dimensional (3D) measurement of the outer and inner/effective.
Christopher S. Grubb et al. JACEP 2019;j.jacep
Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. Diagnosis at presentation and diagnoses finally reached.
Miyako Igarashi et al. JACEP 2018;4:
James S. Gammie et al. JACC 2018;71:25-36
Michael V. McConnell et al. JACC 2018;71:
Jeffrey L. Anderson et al. JACC 2007;50:e1-e157
Rick A. Nishimura et al. JACC 2014;63:e57-e185
A Novel Truncating Variant in FLNC-Encoded Filamin C May Serve as a Proarrhythmic Genetic Substrate for Arrhythmogenic Bileaflet Mitral Valve Prolapse.
Matias B. Yudi et al. JACC 2018;71:
Philipp Blanke et al. JIMG 2015;8:
Sung-Han Yoon et al. JACC 2017;69:
Recurrent polymorphic ventricular tachycardia initiated by Purkinje ectopy in a patient with cardiac sarcoidosis  Faisal Matto, MD, Mohsan Chaudhry, MD,
Volume 13, Issue 1, Pages (January 2016)
Mackram F. Eleid et al. JIMG 2016;9:
A case of sustained ventricular tachycardia due to pembrolizumab
HeartRhythm Case Reports
Ensuring adequate circulation to sustain life (Algorithm 3)
Presentation transcript:

Lars A. Dejgaard et al. JACC 2018;72:1600-1609 Mitral Annulus Disjunction (MAD) Arrhythmic Syndrome One hundred and sixteen patients with mitral annulus disjunction (MAD) were enrolled in the study, of which 14 had experienced aborted cardiac arrest (ACA) or sustained ventricular tachycardia (VT) (top). (Top left) An echocardiogram with pronounced MAD. (Top right) An original electrocardiogram (ECG) from an implantable loop recorder from one of the study participants. A total of 90 patients with MAD had concomitant mitral valve prolapse (MVP) (bottom left), while 26 patients with MAD did not have MVP (bottom right). Severe ventricular arrhythmias (ACA or VT) were frequent in the study participants, and were more prevalent in MAD without MVP, chi-square test, p = 0.003. Lars A. Dejgaard et al. JACC 2018;72:1600-1609 2018 The Authors